Ernexa Therapeutics Inc. (ERNA) › Shares OutstandingErnexa Therapeutics Inc. (ERNA) — Shares OutstandingAnnual figures by fiscal year, from SEC filings.2010: 60.8K2011: 60.9K2012: 71.12M2013: 78.65M2014: 92.37M2015: 1.85M2016: 2.26M2017: 2.52M2018: 2.88M2019: 2.90M2020: 02021: 2.60M2022: 5.13M2023: 5.41M2024: 3.43M2025: 7.85M7.85M2010Shares Outstanding (shares)2025Fiscal YearShares OutstandingChange YoY20257.85M+129.2%20243.43M-36.7%20235.41M+5.5%20225.13M+97.1%20212.60M—20200-100.0%20192.90M+0.9%20182.88M+14.0%20172.52M+11.5%20162.26M+22.3%20151.85M-98.0%201492.37M+17.4%201378.65M+10.6%201271.12M+116634.8%201160.9K+0.3%201060.8K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresDividends Per Share